STILAMIN

This brand name is authorized in Brazil, Hong Kong SAR China, Singapore, South Africa.

Active ingredients

The drug STILAMIN contains one active pharmaceutical ingredient (API):

1	Somatostatin UNII F6R2N217HS - SOMATOSTATIN ACETATE
	Somatostatin is a cyclic tetradecapeptide regulating many endocrine and nervous system functions. Somatostatin inhibits release of adenohypophyseal growth hormone, thyrotropin and corticotropin, pancreatic insulin and glucagon, gastric mucosal gastrin, intestinal mucosal secretin, and renal renin by binding to specific somatostatin receptors (SSTR), which are cell surface G protein-coupled receptors expressed in a tissue-specific manner.
	Read more about Somatostatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01CB01	Somatostatin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CB Somatostatin and analogues
Discover more medicines within H01CB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	525415120047017, 525418080049903
HK	Department of Health Drug Office	33269, 67229
SG	Health Sciences Authority	06135P
ZA	Health Products Regulatory Authority	28/21.10/0136